Multicenter, Randomized, Double-blind, Placebo-controlled Pilot Study of Treamid Efficacy and Safety in the Rehabilitation of Patients After COVID-19 Pneumonia
Latest Information Update: 06 Apr 2021
Price :
$35 *
At a glance
- Drugs Treamid (Primary)
- Indications COVID-19 pneumonia
- Focus Therapeutic Use
- Sponsors Pharmenterprises
- 02 Apr 2021 Status changed from active, no longer recruiting to completed.
- 17 Nov 2020 Status changed from recruiting to active, no longer recruiting.
- 30 Sep 2020 Status changed from not yet recruiting to recruiting.